The DOI matches its Crossref record.
Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis.
Open accessAbstract
A variety of adherent sarcoma, carcinoma and normal cells are surrounded in vitro by thick, transparent zones (approximately equal to 9 micron thick) that spleen cells and a variety of other cells and particles cannot penetrate. Seven lymphoblastoid cell lines did not possess such halos. The presence of these halos around adherent fibrosarcoma cells appeared to protect them from lymphocyte-mediated cytolysis. Hyaluronidase treatment, which destroyed the halo and allowed lymphocytes to approach the tumor cell membrane, enhanced the cytotoxic action of immune but not of normal spleen cells. These observations, in addition to highlighting a little-known feature of the cell surface, may also be of general relevance to the in vitro and in vivo killing of tumor cells by immune effector cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hyaluronan fragments: An information-rich system
Stern, R., Asari, A. A., & Sugahara, K. N. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.05.009 · Cited by 1,132
CD44: Structure, Function and Association with the Malignant Process
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60101-3 · Cited by 1,016
Misra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
Hyaluronan, a Crucial Regulator of Inflammation
Petrey, A. C., & de la Motte, C. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00101 · Cited by 514
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490
Glycosaminoglycans in Morphogenesis
Toole, B. P. (1981) · Cell Biology of Extracellular Matrix · doi:10.1007/978-1-4613-0881-2_10 · Cited by 433
Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses
Menzel, E. J., & Farr, C. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00195-5 · Cited by 346
Devising a pathway for hyaluronan catabolism: are we there yet?
Stern, R. (2003) · Glycobiology · doi:10.1093/glycob/cwg112 · Cited by 337
Toole, B. P. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00171.x · Cited by 320
Hyaluronan in wound healing: Rediscovering a major player
Aya, K. L., & Stern, R. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12214 · Cited by 317
Tammi, R. H., Kultti, A., Kosma, V.-M., Pirinen, R., Auvinen, P., & Tammi, M. I. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.005 · Cited by 272
Experimentally induced mammary tumors in rats
Russo, J., & Russo, I. H. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806074 · Cited by 267
Fascial components of the myofascial pain syndrome
Stecco, A., Gesi, M., Stecco, C., & Stern, R. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0352-9 · Cited by 270
Hyaluronan in skin: aspects of aging and its pharmacologic modulation
Stern, R., & Maibach, H. I. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.09.013 · Cited by 254
Targeting ECM Disrupts Cancer Progression
Venning, F. A., Wullkopf, L., & Erler, J. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00224 · Cited by 254
Beldman, T. J., Senders, M. L., Alaarg, A., Pérez-Medina, C., Tang, J., Zhao, Y., Fay, F., Deichmöller, J., Born, B., Desclos, E., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b01385 · Cited by 196
The role of hyaluronan in renal cell carcinoma
Jin, C., & Zong, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127828 · Cited by 17
Metadata
- Authors
- McBride, W. H., & Bard, J. B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1979-02-01
- Volume
- 149
- Issue
- 2
- Pages
- 507-515
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2105865292
- Cited by
- 192
- References
- 0
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.